Pulmonx Corp Stock Investor Sentiment
| LUNG Stock | USD 6.45 0.15 2.38% |
Roughly 60% of Pulmonx Corp's investor base is looking to short. The analysis of overall sentiment of trading Pulmonx Corp stock suggests that many investors are alarmed at this time. The current market sentiment, together with Pulmonx Corp's historical and current headlines, can help investors time the market. In addition, many technical investors use Pulmonx Corp stock news signals to limit their universe of possible portfolio assets.
Pulmonx |
Pulmonx Corp Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Pulmonx Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Pulmonx Corp that are available to investors today. That information is available publicly through Pulmonx media outlets and privately through word of mouth or via Pulmonx internal channels. However, regardless of the origin, that massive amount of Pulmonx data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pulmonx Corp news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pulmonx Corp relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pulmonx Corp's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pulmonx Corp alpha.
Pulmonx Corp Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Acquisition by Geoffrey Rose of 34500 shares of Pulmonx Corp subject to Rule 16b-3 | 09/06/2024 |
2 | Disposition of 20000 shares by Glendon French of Pulmonx Corp at 8.09 subject to Rule 16b-3 | 09/12/2024 |
3 | Disposition of 20000 shares by Glendon French of Pulmonx Corp at 6.52 subject to Rule 16b-3 | 10/17/2024 |
4 | Pulmonx director sells 130,399 in common stock | 10/21/2024 |
5 | Pulmonx Corp Q3 2024 Earnings Revenue Hits 20.4M, EPS at -0.36, Surpassing Estimates | 10/30/2024 |
6 | Geneial Secures Major Contract with RENCI and NHLBI to Partner with ARPA-H to Transform Biomedical Data Standardization with Advanced AI | 10/31/2024 |
7 | Pulmonx Corporation Q3 2024 Earnings Call Transcript | 11/01/2024 |
8 | TLI Investigators William Stringer MD and Asghar Abbasi PhD, along with Ke Zhang MD of Allerdia Inc., receive 2 Million NIHNHLBI Grant to Develop Novel Point-of... | 11/06/2024 |
9 | FMR LLC Bolsters Stake in Pulmonx Corp - GuruFocus.com | 11/12/2024 |
10 | Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference | 11/20/2024 |
11 | Insider Selling Pulmonx Co. Director Sells 20,000 Shares of Stock | 11/27/2024 |
Complementary Tools for Pulmonx Stock analysis
When running Pulmonx Corp's price analysis, check to measure Pulmonx Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pulmonx Corp is operating at the current time. Most of Pulmonx Corp's value examination focuses on studying past and present price action to predict the probability of Pulmonx Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pulmonx Corp's price. Additionally, you may evaluate how the addition of Pulmonx Corp to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |